Gender Differences in the Diagnosis of Dyslipidemia: ESCARVAL-GENERO.
Cristina Soriano-MaldonadoAdriana López PinedaDomingo Orozco-BeltranJosé Antonio Quesada RicoJose Luis Alfonso-SanchezVicente Pallarés-CarrataláJorge Navarro-PerezVicente F Gil-GuillenJose M Martin-MorenoConcepción Carratalá-MunueraPublished in: International journal of environmental research and public health (2021)
Evidence shows that objectives for detecting and controlling dyslipidemia are not being effectively met, and outcomes differ between men and women. This study aimed to assess gender-related differences in diagnostic inertia around dyslipidemia. This ambispective, epidemiological, cohort registry study included adults who presented to public primary health care centers in a Spanish region from 2008 to 2012, with dyslipidemia and without cardiovascular disease. Diagnostic inertia was defined as the registry of abnormal diagnostic parameters-but no diagnosis-on the person's health record in a window of six months from inclusion. A total of 58,970 patients were included (53.7% women) with a mean age of 58.4 years in women and 57.9 years in men. The 6358 (20.1%) women and 4312 (15.8%) men presenting diagnostic inertia had a similar profile, although in women the magnitude of the association with younger age was larger. Hypertension showed a larger association with diagnostic inertia in women than in men (prevalence ratio 1.81 vs. 1.56). The overall prevalence of diagnostic inertia in dyslipidemia is high, especially in women. Both men and women have a higher risk of cardiovascular morbidity and mortality.